source
- Medicare cuts projected spending on new Alzheimer’s drugs as uptake remains lowMedicare is spending far less on the recently approved Alzheimer’s treatments Leqembi and Kisunla than officials had anticipated. The Centers for Medicare and Medicaid Services said the agency does…
- Providers and insurers vie to influence upcoming No Surprises Act arbitration ruleThe federal government is preparing to release a final rule that will reshape the arbitration process under the No Surprises Act. Health care providers and insurers are both scrambling to have thei…